Security Snapshot

Encompass Health Corp - Common Stock (EHC) Institutional Ownership

CUSIP: 29261A100

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

589

Shares (Excl. Options)

97,431,629

Price

$106.14

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
EHC on NYSE
Shares outstanding
99,498,517
Price per share
$105.67
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
97,431,629
Total reported value
$10,344,606,776
% of total 13F portfolios
0.01%
Share change
+3,635,405
Value change
+$353,784,099
Number of holders
589
Price from insider filings
$105.67
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • EHC - Encompass Health Corp - Common Stock is tracked under CUSIP 29261A100.
  • 589 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 589 to 245 between Q4 2025 and Q1 2026.
  • Reported value moved from $10,344,606,776 to $1,361,828,211.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 589 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 29261A100?
CUSIP 29261A100 identifies EHC - Encompass Health Corp - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Encompass Health Corp - Common Stock (EHC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 5.3% $506,248,256 5,233,622 Vanguard Capital Management 31 Mar 2026
Invesco Ltd. 4.9% $535,910,573 4,972,725 Invesco Ltd. 31 Dec 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 5% $480,902,965 4,971,601 Vanguard Portfolio Management 31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP 4% $456,931,210 4,030,442 Wellington Management Group LLP 31 Dec 2024

As of 31 Dec 2025, 589 institutional investors reported holding 97,431,629 shares of Encompass Health Corp - Common Stock (EHC). This represents 98% of the company’s total 99,498,517 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Encompass Health Corp - Common Stock (EHC) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 10% 10,308,857 +4.4% 0.02% $1,094,182,135
VANGUARD GROUP INC 10% 10,130,029 -1.1% 0.02% $1,075,201,277
Invesco Ltd. 5% 4,972,725 -3% 0.08% $527,805,000
PRICE T ROWE ASSOCIATES INC /MD/ 4.8% 4,805,413 +25% 0.05% $510,047,000
WELLINGTON MANAGEMENT GROUP LLP 3.4% 3,384,877 +22% 0.06% $359,270,845
STATE STREET CORP 3.1% 3,087,890 +0.21% 0.01% $327,748,645
T. Rowe Price Investment Management, Inc. 2.7% 2,722,887 +27% 0.18% $289,008,000
FULLER & THALER ASSET MANAGEMENT, INC. 2.1% 2,053,690 -0.4% 0.74% $217,978,644
GEODE CAPITAL MANAGEMENT, LLC 2% 1,946,134 +7.6% 0.01% $206,605,252
ALLIANCEBERNSTEIN L.P. 1.9% 1,866,768 -26% 0.06% $198,138,756
DIMENSIONAL FUND ADVISORS LP 1.6% 1,624,137 +0.49% 0.04% $172,395,762
MILLENNIUM MANAGEMENT LLC 1.4% 1,435,035 +17% 0.11% $152,314,615
RAYMOND JAMES FINANCIAL INC 1.4% 1,374,682 -11% 0.05% $147,073,895
NORGES BANK 1.3% 1,255,148 0.01% $133,221,409
Thrivent Financial for Lutherans 1.2% 1,176,582 -1.5% 0.22% $124,659,000
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.2% 1,163,834 +9% 0.07% $123,529,341
JPMORGAN CHASE & CO 1.1% 1,099,046 -22% 0.01% $116,652,812
Sumitomo Mitsui Trust Group, Inc. 1% 1,010,608 +33% 0.06% $107,265,933
BANK OF AMERICA CORP /DE/ 0.97% 961,184 +11% 0.01% $102,020,071
Qube Research & Technologies Ltd 0.96% 951,702 +37% 0.14% $101,013,650
NORTHERN TRUST CORP 0.95% 949,522 -3.6% 0.01% $100,782,265
MORGAN STANLEY 0.92% 919,028 +17% 0.01% $97,545,786
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 0.92% 915,920 +14% 0.27% $97,215,749
BROWN ADVISORY INC 0.92% 912,762 -9.9% 0.14% $96,880,551
FRANKLIN RESOURCES INC 0.91% 901,047 -16% 0.02% $95,637,129

Institutional Holders of Encompass Health Corp - Common Stock (EHC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 14,077,904 $1,361,828,211 +$15,641,699 $96.73 245
2025 Q4 97,431,629 $10,344,606,776 +$353,784,099 $106.14 589
2025 Q3 93,686,723 $11,896,053,253 -$135,234,226 $127.02 603
2025 Q2 94,968,235 $11,642,879,160 -$49,112,078 $122.63 603
2025 Q1 95,615,973 $9,683,390,579 +$19,223,151 $101.28 534
2024 Q4 95,688,892 $8,837,272,246 -$61,337,557 $92.35 540
2024 Q3 95,659,986 $9,240,740,107 -$28,092,689 $96.64 478
2024 Q2 95,815,590 $8,220,005,999 -$60,422,230 $85.79 476
2024 Q1 97,703,422 $8,070,672,559 +$16,673,851 $82.58 433
2023 Q4 97,223,556 $6,487,871,907 +$126,291,067 $66.72 429
2023 Q3 94,211,639 $6,326,664,657 +$24,828,296 $67.16 410
2023 Q2 93,484,125 $6,330,038,243 +$9,034,551 $67.71 380
2023 Q1 93,612,402 $5,065,388,681 -$121,237,618 $54.10 384
2022 Q4 96,070,844 $5,746,729,705 +$9,797,176 $59.81 368
2022 Q3 96,958,614 $4,388,175,997 +$140,328,300 $45.23 325
2022 Q2 91,599,655 $5,129,979,182 -$75,940,650 $56.05 367
2022 Q1 94,188,292 $6,688,146,207 +$180,281,875 $71.11 399
2021 Q4 91,512,815 $5,963,921,386 -$30,961,306 $65.26 397
2021 Q3 91,185,917 $6,852,134,068 -$52,652,075 $75.04 430
2021 Q2 91,493,382 $7,141,491,218 +$213,843 $78.03 409
2021 Q1 92,312,962 $7,562,692,331 +$3,926,033 $81.90 398
2020 Q4 92,274,413 $7,632,521,664 -$63,397,436 $82.69 396
2020 Q3 92,464,254 $6,004,059,199 +$39,210,352 $64.98 367
2020 Q2 91,927,091 $5,693,124,070 +$51,792,099 $61.93 368
2020 Q1 91,105,048 $5,833,264,260 +$52,464,250 $64.03 364
2019 Q4 90,001,581 $6,236,071,239 +$91,472,066 $69.27 386
2019 Q3 88,484,154 $5,598,476,445 -$18,802,705 $63.28 347
2019 Q2 89,198,111 $5,639,749,550 +$7,601,931 $63.36 384
2019 Q1 90,121,856 $5,247,040,194 +$18,787,364 $58.40 411
2018 Q4 89,690,946 $5,514,671,892 +$22,743,172 $61.70 431
2018 Q3 89,001,044 $6,908,383,556 -$123,374,722 $77.95 420
2018 Q2 90,646,004 $6,113,554,537 -$37,690,220 $67.72 377
2018 Q1 91,402,381 $5,203,639,355 +$4,844,225,974 $57.17 346
2017 Q4 6,107,530 $301,944,000 +$263,780,365 $49.41 40
2017 Q3 86 $3,000 +$663 $34.88 1
2017 Q2 67 $3,000 $44.78 1
2017 Q1 67 $2,000 -$776 $29.85 1
2016 Q4 93 $3,000 +$1,387 $32.26 1
2016 Q3 50 $2,000 $40.00 1
2016 Q2 50 $1,000 -$1,120 $20.00 1
2016 Q1 73 $3,000 +$2,000 $47.27 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .